Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-κB signaling pathways

Oncogene volume 29, pages 4307–4316 (2010)Cite this article

Subjects

Abstract

The Ras-assocation domain family (RASSF) of tumor suppressor proteins until recently contained six proteins named RASSF1–6. Recently, four novel family members, RASSF7–10, have been identified by homology searches for RA-domain-containing proteins. These additional RASSF members are divergent and structurally distinct from RASSF1–6, containing an N-terminal RA domain and lacking the Sav/RASSF/Hpo (SARAH) domain. Here, we show that RASSF8 is ubiquitously expressed throughout the murine embryo and in normal human adult tissues. Functionally, RNAi-mediated knockdown of RASSF8 in non-small-cell lung cancer (NSCLC) cell lines, increased anchorage-independent growth in soft agar and enhanced tumor growth in severe combined immunodeficiency (SCID) mice. Furthermore, EdU staining of RASSF8-depleted cells showed growth suppression in a manner dependent on contact inhibition. We show that endogenous RASSF8 is not only found in the nucleus, but is also membrane associated at sites of cell–cell adhesion, co-localizing with the adherens junction (AJ) component β-catenin and binding to E-cadherin. Following RASSF8 depletion in two different lung cancer cell lines using alternative small interfering RNA (siRNA) sequences, we show that AJs are destabilized and E-cadherin is lost from the cell membrane. The AJ components β-catenin and p65 are also lost from sites of cell–cell contact and are relocalized to the nucleus with a concomitant increase in β-catenin-dependent and nuclear factor-κB (NF-κB)-dependent signaling following RASSF8 depletion. RASSF8 may also be required to maintain actin -cytoskeletal organization since immunofluorescence analysis shows a striking disorganization of the actin- cytoskeleton following RASSF8 depletion. Accordingly, scratch wound healing studies show increased cellular migration in RASSF8-deficient cells. These results implicate RASSF8 as a tumor suppressor gene that is essential for maintaining AJs function in epithelial cells and have a role in epithelial cell migration.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Brembeck FH, Rosário M, Birchmeier W . (2006). Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16: 51–59.

    Article  CAS  PubMed  Google Scholar 

  • Charalambous M, Smith FM, Bennett WR, Crew TE, Mackenzie F, Ward A . (2003). Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism. Proc Natl Acad Sci USA 100: 8292–8297.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen L, Johnson RC, Milgram SL . (1998). P-CIP1, a novel protein that interacts with the cytosolic domain of peptidylglycine alpha-amidating monooxygenase, is associated with endosomes. J Biol Chem 273: 33524–33532.

    Article  CAS  PubMed  Google Scholar 

  • Dallol A, Agathanggelou A, Fenton SL, Ahmed-Choudhury J, Hesson L, Vos MD et al. (2004). RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res 64: 4112–4116.

    Article  CAS  PubMed  Google Scholar 

  • Dallol A, Agathanggelou A, Tommasi S, Pfeifer GP, Maher ER, Latif F . (2005). Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res 65: 7653–7659.

    Article  CAS  PubMed  Google Scholar 

  • Dallol A, Hesson LB, Matallanas D, Cooper WN, O'Neill E, Maher ER et al. (2009). RAN GTPase is a RASSF1A effector involved in controlling microtubule organization. Curr Biol 19: 1227–1232.

    Article  CAS  PubMed  Google Scholar 

  • Debeer P, Schoenmakers EF, Twal WO, Argraves WS, De Smet L, Fryns JP et al. (2002). The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly. J Med Genet 39: 98–104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dejana E, Rudini N . (2008). Adherens junctions. Curr Biol 18: R1080-2.

  • Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP et al. (2002). beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2: 323–334.

    Article  CAS  PubMed  Google Scholar 

  • Deng J, Xia W, Miller SA, Wen Y, Wang HY, Hung MC . (2004). Crossregulation of NF-kappaB by the APC/GSK-3bet/beta-catenin pathway. Mol Carcinog 39: 139–146.

    Article  CAS  PubMed  Google Scholar 

  • Downward J . (2009). Cancer: A tumour gene’s fatal flaws. Nature 462: 44–45.

    Article  CAS  PubMed  Google Scholar 

  • Falvella FS, Manenti G, Spinola M, Pignatiello C, Conti B, Pastorino U et al. (2006). Identification of RASSF8 as a candidate lung tumor suppressor gene. Oncogene 25: 3934–3938.

    Article  CAS  PubMed  Google Scholar 

  • Hayden MS, Ghosh S . (2008). Shared principles in NF-kappaB signaling. Cell 132: 344–362.

    Article  CAS  PubMed  Google Scholar 

  • Hesson LB, Cooper WN, Latif F . (2007a). The role of RASSF1A methylation in cancer. Dis Markers 23: 73–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hesson LB, Cooper WN, Latif F . (2007b). Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 26: 7283–7301.

    Article  CAS  PubMed  Google Scholar 

  • Hesson LB, Dunwell TL, Cooper WN, Catchpoole D, Brini AT, Chiaramonte R et al. (2009). The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias. Mol Cancer 8: 42.

    Article  PubMed  PubMed Central  Google Scholar 

  • Katagiri K, Maeda A, Shimonaka M, Kinashi T . (2003). RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 4: 741–748.

    Article  CAS  PubMed  Google Scholar 

  • Langton PF, Colombani J, Chan EH, Wepf A, Gstaiger M, Tapon N . (2009). The dASPP-dRASSF8 complex regulates cell-cell adhesion during drosophila retinal morphogenesis. Curr Biol 19: 1969–1978.

    Article  CAS  PubMed  Google Scholar 

  • MacDonald BT, Tamai K, He X . (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Richter AM, Pfeifer GP, Dammann RH . (2009). The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta 1796: 114–128.

    CAS  PubMed  Google Scholar 

  • Rodriguez-Viciana P, Sabatier C, McCormick F . (2004). Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 24: 4943–4954.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Scheel H, Hofmann K . (2003). A novel interaction motif, SARAH, connects three classes of tumor suppressor. Curr Biol 13: R899R900.

    Article  Google Scholar 

  • Sherwood V, Manbodh R, Sheppard C, Chalmers AD . (2008). RASSF7 is a member of a new family of RAS association domain-containing proteins and is required for completing mitosis. Mol Biol Cell 19: 1772–1782.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Solanas G, Porta-de-la-Riva M, Agustí C, Casagolda D, Sánchez-Aguilera F, Larriba MJ et al. (2008). E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci 121 (Pt 13): 2224–2234.

    Article  CAS  PubMed  Google Scholar 

  • Vos MD, Martinez A, Elam C, Dallol A, Taylor BJ, Latif F et al. (2004). A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res 64: 4244–4250.

    Article  CAS  PubMed  Google Scholar 

  • Wang F, Grigorieva EV, Li J, Senchenko VN, Pavlova TV, Anedchenko EA et al. (2008). HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro. PLoS One 3: e3031.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Work in FL's laboratory is supported by Cancer Research UK, Breast Cancer Campaign and Sport Aiding Medical Research for Kids (SPARKS). Work in ADC's laboratory is funded by MRC and Cancer Research UK, and AR by a Marie Curie PhD studentship. EZ was supported by research grants from the Swedish Cancer Society, the Swedish Research Council and the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Swedish Instituteand Karolinska Institute.

Author information

Author notes

  1. F E Lock and N Underhill-Day: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Medical and Molecular Genetics, Institute of Biomedical Research, University of Birmingham, Birmingham, UK

    F E Lock, N Underhill-Day, T Dunwell, W Cooper, L Hesson, E R Maher & F Latif

  2. Systems Biology Ireland, University College Dublin, Dublin, Ireland

    D Matallanas & W Kolch

  3. Department of Biology and Biochemistry, Centre for Regenerative Medicine, University of Bath, Bath, UK

    A Recino, A Ward & A D Chalmers

  4. Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden

    T Pavlova & E Zabarovsky

  5. School of Dentistry, St Chads Queensway, University of Birmingham, Birmingham, UK

    M M Grant

Authors
  1. F E Lock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Underhill-Day
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Dunwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Matallanas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Hesson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Recino
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T Pavlova
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E Zabarovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M M Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. E R Maher
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. A D Chalmers
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. W Kolch
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. F Latif
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F Latif.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lock, F., Underhill-Day, N., Dunwell, T. et al. The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-κB signaling pathways. Oncogene 29, 4307–4316 (2010). https://doi.org/10.1038/onc.2010.192

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.192

Keywords

This article is cited by

Search

Advanced search

Quick links